Tags » Michael Best

Can The Minimum Period Of 5 years Established By NAFTA For Regulatory Data Exclusivity Be Extended In Mexico For Biological Medical Products?

In Mexico, there is no specific body of legislation governing data protection exclusivity (DPE), also known as regulatory exclusivity, for chemical drugs, biological medical products and new indications. 627 more words

Lisa Mueller

Thoughts On How Women Can Maintain Ambition Throughout Their Entire Career

An April, 2004 article in the Harvard Business Review examined whether women lacked “ambition.” According to the article, women generally hate the word “ambition” and associate it with egotism, selfishness, self-aggrandizement or the manipulative use of others for one’s end. 546 more words

Lisa Mueller

A New Beginning? The Brazilian Patent And Trademark Office Has A New President.

Mr. Luiz Otávio Pimentel has been appointed as the new president of INPI (the Brazilian Patent and Trademark Office – BRPTO). The official notice for the nomination was published yesterday, July 28, 2015, in the Federal Register. 284 more words


New Patent Examination Guidance In Canada For Evaluating Medical Diagnostic Methods: Will Canada's Application Be More Flexible Than The U.S.?

Patentable Subject Matter in Canada

In Canada, patentable subject matter is embodied in section 2 of the Canadian Patent Act (Patent Act), which defines an invention as “any new and useful art, process, machine, manufacture or composition of matter, or any new and useful improvement in any art, process, machine, manufacture or composition of matter”. 1,456 more words

Lisa Mueller

Brazil: Strategies and Trends on Intellectual Property Technology Law and Litigation

On July 28 and July 29, Licks Attorneys and Quinn Emanuel Urquhart & Sullivan, LLP will be hosting a seminar in California on strategies and trends in intellectual property law in Brazil. 62 more words


Presentations from 6/14 BRIC Panel at BIO Now Available

Did you miss the BRIC panel “Strategies for Successfully Mastering the Different Challenges of the IP Systems in the BRIC Countries and U.S. in the Pharmaceutical and Life Sciences Sectors,” presented in conjunction with the 2015 BIO International Convention? 16 more words

Pre-Grant Submissions and Post-Grant Review Proceedings in Brazil – Part 6 of an 8 Part Series

This is Part 6 of an 8-part series examining post-grant review proceedings, oppositions, and third party observations in the U.S., BRIC and several non-BRIC countries.  To see Part 1, Post-Grant Oppositions in Japan, click… 879 more words